Chapter 4: Pharmacology

Pharmacokinetics describes the journey drugs take through the body, encompassing absorption through various routes, distribution to target tissues, metabolism by hepatic enzymes, and eventual excretion. Understanding these processes is essential because they determine drug concentration levels over time and influence therapeutic effectiveness. Pharmacodynamics, by contrast, focuses on the mechanisms by which drugs produce their intended effects, particularly how psychotropic medications modulate neurotransmitter systems and affect neural signaling. The chapter emphasizes the critical relationship between drug half-life and dosing schedules, explaining why some medications require frequent administration while others maintain therapeutic levels with daily or weekly dosing. Genetic variation in metabolic enzymes, particularly cytochrome P450 isoforms, accounts for substantial individual differences in drug response, creating a rationale for personalized medicine approaches in mental health treatment. The blood-brain barrier presents a unique pharmacological challenge, as its selective permeability determines which medications can access central nervous system targets and which remain excluded. Receptor pharmacology is explored in detail, distinguishing between agonistic effects that activate receptors, antagonistic effects that block them, and reuptake inhibition mechanisms that increase neurotransmitter availability at synaptic sites. The chapter addresses practical clinical challenges including drug-drug interactions that alter metabolism, side effect profiles that influence patient tolerability, and adherence barriers that compromise treatment outcomes. By integrating these concepts, clinicians can better anticipate individual medication responses, optimize dosing decisions, and recognize when pharmacological interventions require adjustment or combination strategies.